GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA
Delisted
GRNA was delisted on the 21st of July, 2023.
50 hedge funds and large institutions have $65.2M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+11
Holders Change %
+28.21%
% of All Funds
0.85%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
24
Increased
13
Reduced
8
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$1.47M |
2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$547K |
3 |
State Street
Boston,
Massachusetts
|
+$424K |
4 |
Swiss National Bank
Zurich,
Switzerland
|
+$256K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$246K |
Top Sellers
1 |
OCMH
Oxbow Capital Management (HK)
Hong Kong
|
-$4.65M |
2 |
PVI
Pura Vida Investments
New York
|
-$3.85M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.21M |
4 |
Jane Street
New York
|
-$686K |
5 |
Citadel Advisors
Miami,
Florida
|
-$604K |